Optimizing Outcomes With Oral Antiplatelet Therapies
  • Program Overview
    Optimizing Outcomes With Oral Antiplatelet Therapies
    Online presentation and downloadable slides covering key concepts in selecting oral antiplatelet therapies.
  • Featured content
    In my approach to antiplatelet therapy for patients with PAD, I maximize available data and draw from coronary guidelines when necessary.
    Date Posted: 12/9/2015
  • Featured content
    In this interactive presentation, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, reviews current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.
  • 1
  • 2
  • 3

Latest Content

4 of 4 Shown
  • How I Use the New DAPT Score to Determine Optimal Duration of DAPT

    Christopher P. Cannon MD - 1/22/2016 3 comments / Last Comment: 8/26/2016
    Results from a recent subanalysis of the DAPT study have the potential to help clinicians address the challenging question of whether to extend DAPT duration for patients with coronary stents.
  • Antiplatelet Therapy in Peripheral Artery Disease: What I Do and Why

    Joshua A. Beckman MD - 12/9/2015 6 comments / Last Comment: 8/26/2016
    In my approach to antiplatelet therapy for patients with PAD, I maximize available data and draw from coronary guidelines when necessary.
  • Interactive Virtual Presentation

    Optimizing Outcomes With Oral Antiplatelet Therapies

    In this interactive presentation, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, reviews current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.
    Faculty: Deepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC
    Released: 10/2/2015
  • Optimizing Outcomes With Oral Antiplatelet Therapies

    In this downloadable slideset, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, reviews current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.
    Date Posted: 10/2/2015
4 of 4 Shown
Show 0 More
Loading...